ubdural hematoma (SDH) is a common condition confronting neurosurgeons, resulting in more than 90,000 hospitalizations annually. 6 Morbidity, mortality, and length of stay (LOS) in patients treated with surgical evacuation of SDH are not well described, and the patient characteristics associated with adverse outcomes are not clearly established.
data from the National Inpatient Sample (NIS) database, which is a representative sample of all US hospital admissions. These groups have found a mortality rate of 15% for traumatic SDH treated operatively, 7% for nontraumatic SDH treated operatively, and 12% for SDH overall. 4, 6, 10 Although these above-noted NIS studies have clarified the modern risk of death associated with surgical evacuation of SDH in the US, the general health morbidity associated with surgical treatment of SDH has not been examined. However, the NIS database, while a valuable resource, only captures complications that occur during inpatient stays. Moreover, the accuracy of data about comorbidities and complications in this database is limited, as these data are pulled from the International Classification of Diseases, Ninth Revision (ICD-9) codes in administrative discharge summaries, rather than abstracted directly from charts. Consequently, patient comorbidities and adverse outcomes are generally underreported in the NIS compared with the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP), as we have previously shown. 2 To mitigate the limitations of the above studies, we analyzed data from the ACS NSQIP database. The ACS NSQIP is a national database that includes comorbidity and 30-day outcome data abstracted directly from patient charts based on published, standardized definitions. The ACS NSQIP specifically excludes patients with major trauma, who may have substantial morbidity and mortality related to generalized injury. Using these data, we examined LOS, surgical outcomes including return to the operating room (OR) and wound infection, and more general outcomes ranging from death to urinary tract infections.
Multivariate regression was used to determine patient comorbidities associated with adverse outcomes and prolonged LOS. The results of this study provide surgeons and intensive care unit practitioners with information to make detailed, accurate assessments of surgical risk, and to counsel patients and their families.
methods data source
The ACS NSQIP database, which compiles data from randomly selected surgical patients at more than 370 institutions in the US, was used for this study. 1 This database includes more than 150 prospectively collected perioperative variables about included patients. 11 Trained nurses abstract these data from medical records, operative reports, and patient interviews. Postoperative data are collected for 30 days after surgery for all patients, including discharged patients.
Patients who underwent craniotomy or craniectomy procedures for SDH between 2005 and 2012 were identified in the ACS NSQIP based on the following Current Procedural Terminology (CPT) codes: 61304, 61305, 61312, 61313, 61314, and 61315. The population of patients undergoing these procedures specifically for evacuation of SDH was identified using the ICD-9 codes for SDH (432.1, 852.2, and 852.3). Patients who also underwent aneurysm clipping procedures (CPT codes 61697, 61700, 61698, 61702, and 61703) or embolization (CPT codes 61624 and 61635) were excluded. A waiver of informed consent was granted by our institution's institutional review board.
data collection
Patient demographic characteristics, such as age, sex, height, and weight, were abstracted directly from charts into the ACS NSQIP. Body mass index (BMI) was derived from height and weight, and then categorized according to existing guidelines. 16 Medical comorbidities and adverse events in the 30-day postoperative period were determined by abstracters based on published definitions.
outcomes measures
The primary outcome measure was mortality. Secondary outcomes measured included the occurrence of adverse events other than death, which were grouped as severe adverse events, minor adverse events, and any adverse events, as described previously. 3, 7 Severe adverse events were considered to be prolonged intubation of 48 hours or more, return to the OR, unplanned reintubation, sepsis, venous thromboembolism, coma, stroke, cardiac arrest, septic shock, myocardial infarction (MI), infection of the surgical site or organ space, and acute renal failure. Minor adverse events were considered to be perioperative blood transfusion, urinary tract infection, pneumonia, renal insufficiency, and wound dehiscence. For data reporting, we defined "any adverse event" as the occurrence of at least 1 major or minor adverse event. Each patient was only counted once for each adverse event category, regardless of the number of adverse events in total for a given patient.
Return to the OR was also evaluated as a separate outcome measure. Severe and minor adverse events were considered separately from death because of the high case mortality in this population, which caused concern that death would drive the analysis if death and other adverse events were analyzed together. Lastly, the ACS NSQIP calculates LOS based on admission and discharge dates, so stays longer than 30 days are recorded. However, outcomes are only captured for the first 30 days.
statistical analysis
Statistical analyses were performed using R version 3.1.2. Statistical significance was determined by a 2-tailed α of 0.05. Univariate regressions were performed to assess the relationships between comorbidities and death. Multivariate Poisson regression, with robust sandwich errors, was used to determine the effect of patient factors on mortality, return to the OR, adverse events, and LOS. 21 Age, BMI, sex, and all predictors significant in the univariate regression were included in the multivariate model. Functional status and drinking status were not evaluated as predictors because these variables had large proportions of missing data. For continuous variables, means are reported with standard deviations.
results patient demographics and comorbidities
A total of 746 patients who underwent evacuation of SDH were included in the ACS NSQIP between 2005 and 2012. Data for 196 of these patients were substantially missing, so they were not included in the multivariate analysis. Table 1 shows patient demographics and comorbidities.
The average patient age (± SD) was 70.9 ± 14.1 years, and 64% of patients were male. In terms of functional status, 57% of patients were functionally independent prior to surgery. In terms of BMI, 73% were within normal or overweight classes, and 23% were obese. American Society of Anesthesiologists (ASA) Class 3 or 4 was noted in 43% of patients each. Nine percent of patients with data available consumed more than 2 alcoholic drinks per day in the 2 weeks prior to surgery.
comorbidities
The comorbidities present in this population and the mortality associated with each condition are shown in Table 2 . The most common comorbidity was hypertension (69% of patients), followed by delirium/confusion (43%), and bleeding disorder (29%).
The preoperative factors found to be significantly associated with mortality in the univariate analysis and included in the multivariate analysis were ascites (67%, p = 0.0014), gangrene (67%, p = 0.0428), pneumonia (63%, p = 0.0024), coma (62%, p < 0.0001), dialysis (50%, p < 0.0001), history of MI (50%, p = 0.0326), ventilator dependence (48%, p < 0.0001), severe dyspnea (46%, p = 0.0001), history of congestive heart failure (CHF; 42%, p = 0.0040), bleeding disorder (32%, p < 0.0001), preoperative open wound (29%, p = 0.0266), history of stroke (27%, p = 0.0091), and delirium (26%, p = 0.0016).
postoperative adverse events
Death within 30 days of surgery was a common adverse (Fig. 1) . The decrease in survivorship decelerates over time from about 2% per day between Days 0 and 1 to 0.1% per day at 4 weeks. Table 3 elucidates postoperative adverse events. Mechanical ventilation for 48 hours or more was the single most common adverse event, occurring in 144 patients (19%). Of those patients intubated for more than 2 days, 47% eventually died. Fifty-eight patients (8%) were brought back to the OR for reevacuation of the SDH. Unplanned reintubation and sepsis occurred in 47 (6%) and 46 (6%) patients, respectively. The other severe adverse events, such as deep venous thrombosis (DVT)/pulmonary embolism (PE), coma, stroke, cardiac arrest or MI, and septic shock occurred relatively rarely, arising in 4% or less of cases. Overall, 256 patients (34%) experienced a severe postoperative event aside from death.
A total of 194 patients (26%) experienced a minor adverse event. The most common minor event was perioperative blood transfusion, which accounted for more than half of minor events (107 cases, 14%). Urinary tract infection and pneumonia occurred in 9% (64 cases) and 8% (58 cases), respectively. Progressive renal failure occurred in 7 patients (1%). Any adverse event including death occurred in 356 patients (48%), and any adverse event aside from death occurred in 332 patients (45%).
length of stay
The average LOS in the hospital for all patients was 9.8 ± 9.9 days. In patients who survived, the average LOS was 10.3 ± 10.6 days. Figure 2 is a histogram showing the LOS in patients who survived. Ninety-one percent of patients were inpatient for fewer than 3 weeks, but some patients had very long admissions (up to 71 days).
predictors of adverse events
The results of multivariate regression to identify predictors of adverse events are shown in Table 4 . For each of the studied outcomes (death, return to the OR, severe adverse event, any adverse event, and LOS), a separate multivariate analysis was conducted.
The 
discussion
Surgical evacuation of SDH is a common and effective neurosurgical procedure. 14, 17 However, short-term health outcomes of the procedure, aside from death and recurrence, have not been well characterized. We studied a national sample of 746 patients who underwent surgical drainage of SDH between 2005 and 2012, and describe in detail the comorbidities, adverse postoperative events, and predictors of adverse events in this population. These findings should help neurosurgeons, intensivists, and traumatologists in their decision making and in counseling patients and their families.
patient population
Previous database studies have distinguished between "nontraumatic" and "traumatic" SDH based on ICD-9 codes. 4, 10 However, nontraumatic SDH in this context does not represent true spontaneous hemorrhage, but rather an SDH without a documented known injury. Hence, despite the difference in coding, these patients were considered together in this study. Those patients with coding evidence of aneurysms or other inciting causes of SDH were excluded. Because the ACS NSQIP does not collect data on patients presenting with major trauma, the patient population studied here is therefore patients with SDH caused by relatively minor injury.
Patients undergoing surgery for SDH generally have several comorbidities. Not surprisingly, nearly 70% of patients have hypertension treated with medication. More than 40% of patients had preexisting delirium/confusion, and 20% of patients were ventilator dependent. Bleeding disorders were present in about 30% of patients, and diabetes and history of stroke both had prevalences slightly higher than 20%.
mortality rate
In total, 130 patients in this study died, which equates to a 17% 30-day mortality rate. This is similar to the 15% operatively treated traumatic SDH mortality rate, but substantially higher than the 7% operatively treated nontraumatic SDH mortality rate from NIS data. 4, 10 The most likely explanation for this more than 2-fold difference is that NIS only captures inpatient mortality, whereas NSQIP captures all deaths within 30 days, including at home, in rehabilitation facilities, and in hospices. 1 In addition, the distinction between a traumatic and a nontraumatic SDH based on ICD-9 coding appears dubious, as truly nontraumatic SDH is a rare condition. 15 The selection of codes may reflect the presence of an identifiable, recent trauma in the history rather than the actual underlying cause of bleeding.
The rate at which patients died was greatest immediately following surgery, and decreased with time. At 4 weeks, survivorship decreased by about 0.1% per day compared with 2% per day in the immediate postoperative period. Approximately 50% of patient deaths occurred within 1 week, 80% within 2 weeks, and more than 90% by 3 weeks. The Kaplan-Meier curve suggests that survivorship is asymptotically approaching a plateau near 80%.
length of stay
The average LOS for patients who did not die was about 10 days. While almost 95% of patients were discharged within 1 month, a few patients did have exceptionally long stays of more than 2 months. Nevertheless, the average LOS in this study is shorter than previously published estimates of 15-20 days. 8 
adverse events
Surgeons performing SDH evacuation need to be aware of the high rate of adverse events because more than onethird of patients experienced a severe adverse event other than death. The most common severe adverse event was ventilator dependence for more than 2 days. More importantly, these ventilator-dependent patients ultimately died in nearly 50% of cases. In terms of reoperation, repeat surgery was required in 58 cases (8%), consistent with previous estimates. 4, 13 It should be noted that as with comorbidities, many of the adverse events described here could be ascribed more to the natural history of SDH rather than to surgical intervention, and these outcomes could occur more frequently without intervention. The order of causation-that is, which comes first-is unknown, but the associations are present.
predictors of mortality
In the multivariate model for death, mortality was significantly associated with the presence of ascites, coma prior to surgery, coagulopathy, and dialysis. These results are logical and reasonably suggest that death following SDH is influenced both by the extent of neurological damage and the overall health of the patient at the time of surgery. Whereas coma prior to surgery may, in many cases, reflect the severity of SDH, ascites and dialysis are both markers for poor general health. Similarly, bleeding disorders would worsen any intracranial bleeding, and the exact type of bleeding disorder is beyond the scope of the NSQIP. ASA class was significantly associated with mortality, even when controlling for other morbidities, demonstrating the value of the anesthesiologist's assessment of the patient preoperatively. Lastly, an age less than 60 years was protective against death, as expected. 9 ASA class, delirium, and ventilator dependence were associated with increased LOS and complications other than death. For ventilator dependence, this effect is likely explained both by overall poor health and by the inclusion of mechanical ventilation after surgery for longer than 48 hours as a complication. Male sex was associated with a greater risk of returning to the OR and a higher risk of severe adverse events, likely from a more significant intracranial injury.
The risk factors identified in this study are unsurprising, based on current clinical wisdom and previous work. However, some patient factors that might be expected to influence morbidity and mortality after SDH evacuation did not have a significant effect, such as metastatic cancer and advancing age. The magnitudes of the risks associated with various comorbidities have not been previously reported, and should help surgeons tailor estimates of risk to individual patients. A better understanding of the risk facing a patient will help surgeons in determining the appropriateness of surgical evacuation for SDH, and to counsel patients and families.
limitations of the study
Our study was limited by the information available in the ACS NSQIP database. Some factors that could potentially affect outcomes, such as radiological information about the size and location of bleeding, were not available. As mentioned earlier, these data do not allow for the discrimination of comorbidities existing before the onset of SDH, and also do not allow for neurological examination outside of the variables of delirium and coma. NSQIP data are limited to the first 30 postoperative days, so late adverse events are not considered. Mortality in this largely elderly patient population likely includes some death from causes unrelated to SDH and surgical evacuation. Because the NSQIP includes surgically treated patients only, no comparison could be made to nonoperative cases. Additionally, long-term general and functional outcomes are not available in this database.
